Trial Profile
Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Chorionic gonadotropin
- Indications Infertility
- Focus Pharmacokinetics
- 04 Jan 2018 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2016 ).
- 19 Jan 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016, as reported by ClinicalTrials.gov.
- 19 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.